Velsera Enhances Illumina's Comprehensive Test for Cancer with New Approval in Japan Velsera proudly powers Illumina's TSO Comprehensive test, now approved in Japan, enhancing cancer treatment decisions through genomic profiling.

Velsera Enhances Illumina's Comprehensive Test for Cancer with New Approval in Japan #Japan #Tokyo #Illumina #Velsera #TSO_Comprehensive